Browse by author
Lookup NU author(s): Steven White, Professor James Shaw
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Since the introduction of pancreas transplantation more than 40 years ago, efforts to develop more minimally invasive techniques for endocrine replacement therapy have been in progress, yet this surgical procedure still remains the treatment of choice for diabetic patients with end-stage renal failure. Many improvements have been made in the surgical techniques and immunosuppressive regimens, both of which have contributed to an increasing number of indications for pancreas transplantation. This operation can be justified on the basis that patients replace daily injections of insulin with an improved quality of life but at the expense of a major surgical procedure and lifelong immunosuppression. The various indications, categories, and outcomes of patients having a pancreas transplant are discussed, particularly with reference to the effect on long-term diabetic complications. © 2009 Elsevier Ltd. All rights reserved.
Author(s): White S, Shaw J, Sutherland D
Publication type: Review
Publication status: Published
Journal: The Lancet
Year: 2009
Volume: 373
Issue: 9677
Pages: 1808-1817
ISSN (print): 0140-6736
ISSN (electronic): 1474-547X
URL: http://dx.doi.org/10.1016/S0140-6736(09)60609-7
DOI: 10.1016/S0140-6736(09)60609-7
PubMed id: 19465236
